Back to Agenda
Challenges and Opportunities in Product Quality: Lifecycle Management
Session Chair(s)
Susan Rosencrance, PHD
Acting Director, Office of Generic Drugs, CDER, FDA, United States
The efficacy and safety of a drug product are linked to its quality. Assuring product quality across the product lifecycle is challenging due to the numerous changes made to maintain or enhance product quality and manufacturing efficiency. Regulatory and industry speakers in this session will describe current thinking on product quality lifecycle management.
Learning Objective : Describe FDA's current thinking on drug product quality lifecycle management, from brand name drugs to generics; Discuss specific tools and mechanisms in efficiently managing product lifecycle: Identify existing and upcoming regulatory tools to ease post approval changes.
Speaker(s)
Lifecycle Management Challenges for Accelerated Program and Possible Innovative Solutions
Executive Director, Merck & Co., Inc., United States
Opportunities for Streamlining Postapproval Lifecycle Management Under ICH Q12
Head, International Global Regulatory & Scientific Policy, Merck, Switzerland
Challenges and Opportunities in Lifecycle Management of Product Quality
Director, OLDP, OPQ, CDER, FDA, United States
Have an account?